Cargando…
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
New therapies are required for melanoma. Here, we report that multiple cardiac glycosides, including digitoxin and digoxin, are significantly more toxic to human melanoma cells than normal human cells. This reflects on-target inhibition of the ATP1A1 Na(+)/K(+) pump, which is highly expressed by mel...
Autores principales: | Eskiocak, Ugur, Ramesh, Vijayashree, Gill, Jennifer G., Zhao, Zhiyu, Yuan, Stacy W., Wang, Meng, Vandergriff, Travis, Shackleton, Mark, Quintana, Elsa, Johnson, Timothy M., DeBerardinis, Ralph J., Morrison, Sean J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996948/ https://www.ncbi.nlm.nih.gov/pubmed/27545456 http://dx.doi.org/10.1038/ncomms12336 |
Ejemplares similares
-
Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
por: Eskiocak, Ugur, et al.
Publicado: (2016) -
Metabolic heterogeneity confers differences in melanoma metastatic potential
por: Tasdogan, Alpaslan, et al.
Publicado: (2019) -
Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients
por: Frankel, Arthur E., et al.
Publicado: (2017) -
Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis
por: Shelton, Spencer D., et al.
Publicado: (2023) -
Identifying metabolomic features that predict metastasis of melanoma from a primary site
por: Shi, Xiaolei, et al.
Publicado: (2014)